Invention Grant
- Patent Title: Tricyclic heterocycles as BET protein inhibitors
-
Application No.: US14923105Application Date: 2015-10-26
-
Publication No.: US09624241B2Publication Date: 2017-04-18
- Inventor: Andrew P. Combs , Richard B. Sparks , Thomas P. Maduskuie, Jr.
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D498/04
- IPC: C07D498/04 ; C07D498/06 ; C07D498/16 ; C07D471/06 ; C07D519/00
Abstract:
The present invention relates to tricyclic heterocycles of Formula (I): which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
Public/Granted literature
- US20160046650A1 TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS Public/Granted day:2016-02-18
Information query
